CONTRAFECT CORP (CFRX)
US2123264093 - Common Stock
ContraFect files for stock and warrants offering to raise $15M (NASDAQ:CFRX)
ContraFect plans to raise $15 million through the sale of common stock and warrants. Read more.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the workweek with a detailed breakdown of the biggest pre-market stock movers for Monday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!
RAD Stock Sinks as Rite Aid Files for Ch. 11 Bankruptcy
Rite Aid stock is taking a beating on Monday as investors in RAD react to the company filing for Chapter 11 bankruptcy protection.
Why Is Nxu (NXU) Stock Down Today?
Nxu stock is falling on Monday after the company reported insider selling of its shares as well as addressing a delisting notice.
Why Is Sigma Additive Solutions (SASI) Stock Down 27% Today?
Sigma Additive Solutions stock is sliding lower on Monday as shares of SASI give up gains from an acquisition announcement on Friday!
Why Is ContraFect (CFRX) Stock Up 23% Today?
ContraFect stock is on the move Monday with heavy trading of CFRX as investors react to the latest clinical trial update from the FDA!
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
CF-370 is the first engineered lysin therapeutic targeting Gram-negative pathogens allowed to enter a human trial
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
CF-370 is the first engineered lysin therapeutic targeting Gram-negative pathogens allowed to enter a human trial...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning!
ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
YONKERS, New York, Sept. 19, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the...
ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370
YONKERS, N.Y., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...
ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
YONKERS, N.Y., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...
ContraFect enters a warrant exercise transaction for $9.6M (NASDAQ:CFRX)
A clinical-stage biotechnology company, ContraFect (CFRX) enters into a warrant exercise agreement with an existing accredited investor to purchase 7M shares.In connection with...
ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million
YONKERS, N.Y., June 27, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...
ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company’s Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens
YONKERS, N.Y., June 20, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time for a final look at the biggest pre-market stock movers this week as we check out what's happening on Friday morning!